Subscribe to Newsletter

Basic & Translational Research

Subspecialties Basic & Translational Research

Looking at Listening

If you want to know if someone is empathizing with your tale, watch their pupils…

Business & Profession Health Economics and Policy

Near, Not Far

Little has been done to discover how near vision impairment progresses in a population... Until now.

Subspecialties Retina

Image of the Month

The first subretinal injection of AAV XLRPGR gene therapy into a patient with retinitis pigmentosa.

Subspecialties Retina

A Serious Breach of Trust

| Ruth Steer

How did people react to the news that an unapproved stem cell therapy blinded three patients?

Subspecialties Retina

Retinal Prostheses: The Next Generation

| Mark Hillen

Two approaches that could result in a better retinal implant.

Subspecialties Basic & Translational Research

Benchmarking Dry AMD

| Roisin McGuigan

What does analysis of the last five years of dry AMD literature tell us about the field?

Subspecialties Retina

It’s in Their Bones

| Elad Moisseiev and Susanna Park

Bone marrow stem cells for the treatment of retinal disease are closer than you might think.

Business & Profession Basic & Translational Research

Refractive Surgery's Holy Grail…

| Shafi Balal

Eyedrops for presbyopia.

Business & Profession Basic & Translational Research

Image of the Month

Using an audio interpretive tool to create artwork by, and for, the visually impaired.

Subspecialties Basic & Translational Research

ON Delayed Gratification

| Ruth Steer

Could a newly identified retinal ganglion cell type unlock the mystery of myopia?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.